Table of Contents
ISRN Oncology
Volume 2011, Article ID 527453, 13 pages
http://dx.doi.org/10.5402/2011/527453
Review Article

Brain Metastases from Ovarian Carcinoma

1Department of Obstetrics and Gynecology, Sapir Medical Center, Sackler School of Medicine, University of Tel-Aviv, Kfar-Saba 44281, Israel
2Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel

Received 4 October 2011; Accepted 23 October 2011

Academic Editors: E. Boven, L. Mutti, and D. Tong

Copyright © 2011 Ettie Piura and Benjamin Piura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Langley and I. J. Fidler, “The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs,” International Journal of Cancer, vol. 128, no. 11, pp. 2527–2535, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. P. W. Sperduto, B. Berkey, L. E. Gaspar, M. Mehta, and W. Curran, “A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 2, pp. 510–514, 2008. View at Publisher · View at Google Scholar · View at PubMed
  3. A. Tosoni, M. Ermani, and A. A. Brandes, “The pathogenesis and treatment of brain metastases: a comprehensive review,” Critical Reviews in Oncology/Hematology, vol. 52, no. 3, pp. 199–215, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. I. J. Fidler, “The role of the organ microenvironment in brain metastasis,” Seminars in Cancer Biology, vol. 21, no. 2, pp. 107–112, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. L. J. Schouten, J. Rutten, H. A. M. Huveneers, and A. Twijnstra, “Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma,” Cancer, vol. 94, no. 10, pp. 2698–2705, 2002. View at Publisher · View at Google Scholar
  6. K. Ogawa, Y. Yoshii, Y. Aoki et al., “Treatment and prognosis of brain metastases from gynecological cancers,” Neurologia Medico-Chirurgica, vol. 48, no. 2, pp. 57–62, 2008. View at Publisher · View at Google Scholar
  7. R. Siegel, E. Ward, O. Brawley, and A. Jemal, “Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths,” CA: Cancer Journal for Clinicians, vol. 61, no. 4, pp. 212–236, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Google Scholar
  10. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar
  11. National Cancer Institute, “Surveillance Epidemiology and End Results [SEER],” http://seer.cancer.gov/csr/1975_2007/browse_csr.php.
  12. H. Bonnefoi, R. P. A'Hern, C. Fisher et al., “Natural history of stage IV epithelial ovarian cancer,” Journal of Clinical Oncology, vol. 17, no. 3, pp. 767–775, 1999. View at Google Scholar
  13. R. J. Mayer, R. S. Berkowitz, and C. T. Griffiths, “Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease,” Cancer, vol. 41, no. 2, pp. 776–783, 1978. View at Google Scholar
  14. H. L. Abrams, R. Spiro, and N. Goldstein, “Metastases in carcinoma; analysis of 1000 autopsied cases,” Cancer, vol. 3, no. 1, pp. 74–85, 1950. View at Google Scholar
  15. F. Bergman, “Carcinoma of the ovary. A clinicopathological study of 86 autopsied cases with special reference to mode of spread,” Acta Obstetricia et Gynecologica Scandinavica, vol. 45, no. 2, pp. 211–231, 1966. View at Google Scholar
  16. N. A. Janovski and T. L. Paramanandhan, “Ovarian tumors,” in Major Problems in Obstetrics and Gynecology, N. A. Janovski and T. L. Paramanandhan, Eds., vol. 4, pp. 182–185, W.B. Saunders Company, Philadelphia, Pa, USA, 1973. View at Google Scholar
  17. C. G. Julian, J. Goss, K. Blanchard, and J. D. Woodruff, “Biologic behavior of primary ovarian malignancy,” Obstetrics and Gynecology, vol. 44, no. 6, pp. 873–884, 1974. View at Google Scholar
  18. W. H. Pearse and S. J. Behrman, “Carcinoma of the ovary,” Obstetrics and Gynecology, vol. 3, no. 1, pp. 32–45, 1954. View at Google Scholar
  19. T. Le Chevalier, F. P. Smith, and P. Caille, “Sites of primary malignancies in patients presenting with cerebral metastases: a review of 120 cases,” Cancer, vol. 56, no. 4, pp. 880–882, 1985. View at Google Scholar
  20. D. M. Larson, L. J. Copeland, R. P. Moser, J. M. Malone Jr., D. M. Gershenson, and J. T. Wharton, “Central nervous system metastases in epithelial ovarian carcinoma,” Obstetrics and Gynecology, vol. 68, no. 6, pp. 746–750, 1986. View at Google Scholar
  21. D. F. Kolomainen, J. M. G. Larkin, M. Badran et al., “Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence,” Journal of Clinical Oncology, vol. 20, no. 4, pp. 982–986, 2002. View at Publisher · View at Google Scholar
  22. Y. L. Chen, W. F. Cheng, C. Y. Hsieh, and C. A. Chen, “Brain metastasis as a late manifestation of ovarian carcinoma,” European Journal of Cancer Care, vol. 20, no. 1, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at PubMed
  23. J. Dauplat, N. F. Hacker, R. K. Nieberg, J. S. Berek, T. P. Rose, and S. Sagae, “Distant metastases in epithelial ovarian carcinoma,” Cancer, vol. 60, no. 7, pp. 1561–1566, 1987. View at Google Scholar
  24. G. H. Barker, J. Orledge, and E. Wiltshaw, “Involvement of the central nervous system in patients with ovarian carcinoma,” British Journal of Obstetrics and Gynaecology, vol. 88, no. 7, pp. 690–694, 1981. View at Google Scholar
  25. G. T. Budd, K. D. Webster, R. R. Reimer, P. Martimbeau, and R. B. Livingston, “Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: effect of treatment and incidence of intracranial metastases,” Journal of Surgical Oncology, vol. 24, no. 3, pp. 192–195, 1983. View at Google Scholar
  26. M. Stein, M. Steiner, B. Klein et al., “Involvement of the central nervous system by ovarian carcinoma,” Cancer, vol. 58, no. 9, pp. 2066–2069, 1986. View at Google Scholar
  27. J. Dauplat, R. K. Nieberg, and N. F. Hacker, “Central nervous system metastases in epithelial ovarian carcinoma,” Cancer, vol. 60, no. 10, pp. 2559–2562, 1987. View at Google Scholar
  28. J. Ziegler, P. Gliedman, D. Fass, M. Beckman, A. Neophytides, and A. Steinfeld, “Brain metastases from ovarian cancer,” Journal of Neuro-Oncology, vol. 5, no. 3, pp. 211–215, 1987. View at Google Scholar
  29. W. M. Ross, J. A. Carmichael, and W. E. Shelley, “Advanced carcinoma of the ovary with central nervous system relapse,” Gynecologic Oncology, vol. 30, no. 3, pp. 398–406, 1988. View at Google Scholar
  30. J. R. Hardy and V. J. Harvey, “Cerebral metastases in patients with ovarian cancer treated with chemotherapy,” Gynecologic Oncology, vol. 33, no. 3, pp. 296–300, 1989. View at Google Scholar
  31. B. Piura, M. Glezerman, Y. Galper, S. Segal, and Y. Cohen, “Brain metastases in epithelial ovarian carcinoma; two case reports,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 36, no. 1-2, pp. 203–208, 1990. View at Google Scholar
  32. S. C. Plaxe, P. R. Dottino, R. Lipsztein, J. Dalton, and C. J. Cohen, “Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous system,” Obstetrics and Gynecology, vol. 75, no. 2, pp. 278–281, 1990. View at Google Scholar
  33. P. D. LeRoux, M. S. Berger, J. P. Elliott, and H. K. Tamimi, “Cerebral metastases from ovarian carcinoma,” Cancer, vol. 67, no. 8, pp. 2194–2199, 1991. View at Google Scholar
  34. G. C. Rodriguez, J. T. Soper, A. Berchuck et al., “Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery,” Journal of Clinical Oncology, vol. 10, no. 10, pp. 1553–1560, 1992. View at Google Scholar
  35. M. Bruzzone, E. Campora, S. Chiara et al., “Cerebral metastases secondary to ovarian cancer: still an unusual event,” Gynecologic Oncology, vol. 49, no. 1, pp. 37–40, 1993. View at Publisher · View at Google Scholar · View at PubMed
  36. M. Salvati and L. Cervoni, “Solitary cerebral metastasis from ovarian carcinoma: report of 4 cases,” Journal of Neuro-Oncology, vol. 19, no. 1, pp. 75–77, 1994. View at Publisher · View at Google Scholar
  37. J. P. Geisler and H. E. Geisler, “Brain metastases in epithelial ovarian carcinoma,” Gynecologic Oncology, vol. 57, no. 2, pp. 246–249, 1995. View at Publisher · View at Google Scholar · View at PubMed
  38. G. Cormio, A. Maneo, G. Parma, M. R. Pittelli, M. D. Miceli, and C. Bonazzi, “Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review,” Annals of Oncology, vol. 6, no. 6, pp. 571–574, 1995. View at Google Scholar
  39. M. Suzuki, S. Tsukagoshi, M. Ohwada, Y. Koumura, and I. Sato, “A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment,” Gynecologic Oncology, vol. 74, no. 3, pp. 483–486, 1999. View at Publisher · View at Google Scholar · View at PubMed
  40. Y. Zhao, H. Qian, and W. Li, “Cerebral metastases in patients with epithelial ovarian carcinoma,” Zhonghua Fu Chan Ke Za Zhi, vol. 34, no. 7, pp. 420–422, 1999. View at Google Scholar
  41. M. C. Kaminsky-Forrett, B. Weber, T. Conroy, and D. Spaeth, “Brain metastases from epithelial ovarian carcinoma,” International Journal of Gynecological Cancer, vol. 10, no. 5, pp. 366–371, 2000. View at Publisher · View at Google Scholar
  42. A. Sanderson, S. C. Bonington, B. M. Carrington, D. L. Alison, and J. A. Spencer, “Cerebral metastasis and other cerebral events in women with ovarian cancer,” Clinical Radiology, vol. 57, no. 9, pp. 815–819, 2002. View at Publisher · View at Google Scholar
  43. N. Anupol, S. Ghamande, K. Odunsi, D. Driscoll, and S. Lele, “Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases,” Gynecologic Oncology, vol. 85, no. 3, pp. 487–492, 2002. View at Publisher · View at Google Scholar
  44. B. Pothuri, D. S. Chi, T. Reid et al., “Craniotomy for central nervous system metastases in epithelial ovarian carcinoma,” Gynecologic Oncology, vol. 87, no. 1, pp. 133–137, 2002. View at Publisher · View at Google Scholar
  45. L. Kumar, S. Barge, A. K. Mahapatra et al., “Central nervous system metastases from primary epithelial ovarian cancer,” Cancer Control, vol. 10, no. 3, pp. 244–253, 2003. View at Google Scholar
  46. Z. T. Li and S. L. Fu, “Epithelial ovarian carcinoma metastatic to the brain: report on ten cases with review of literature,” Zhonghua fu Chan Ke Za Zhi, vol. 38, no. 5, pp. 287–289, 2003. View at Google Scholar
  47. Z. R. Cohen, D. Suki, J. S. Weinberg et al., “Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome,” Journal of Neuro-Oncology, vol. 66, no. 3, pp. 313–325, 2004. View at Publisher · View at Google Scholar
  48. S. K. Tay and H. Rajesh, “Brain metastases from epithelial ovarian cancer,” International Journal of Gynecological Cancer, vol. 15, no. 5, pp. 824–829, 2005. View at Publisher · View at Google Scholar · View at PubMed
  49. D. Pectasides, G. Aravantinos, G. Fountzilas et al., “Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature,” Anticancer Research, vol. 25, no. 5, pp. 3553–3558, 2005. View at Google Scholar
  50. G. D'Andrea, R. Roperto, L. Dinia, E. Caroli, M. Salvati, and L. Ferrante, “Solitary cerebral metastases from ovarian epithelial carcinoma: 11 Cases,” Neurosurgical Review, vol. 28, no. 2, pp. 120–123, 2005. View at Publisher · View at Google Scholar · View at PubMed
  51. P. G. Chen, S. Y. Lee, G. H. Barnett et al., “Use of the radiation therapy oncology group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma,” Cancer, vol. 104, no. 10, pp. 2174–2180, 2005. View at Publisher · View at Google Scholar · View at PubMed
  52. E. Kastritis, E. Efstathiou, D. Gika et al., “Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy,” International Journal of Gynecological Cancer, vol. 16, no. 3, pp. 994–999, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. T. J. Kim, S. Song, C. K. Kim et al., “Prognostic factors associated with brain metastases from epithelial ovarian carcinoma,” International Journal of Gynecological Cancer, vol. 17, no. 6, pp. 1252–1257, 2007. View at Publisher · View at Google Scholar · View at PubMed
  54. Y. K. Lee, N. H. Park, J. W. Kim, Y. S. Song, S. B. Kang, and H. P. Lee, “Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer,” Gynecologic Oncology, vol. 108, no. 3, pp. 505–509, 2008. View at Publisher · View at Google Scholar · View at PubMed
  55. J. Sehouli, K. Pietzner, P. Harter et al., “Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study,” Annals of Oncology, vol. 21, no. 11, pp. 2201–2205, 2010. View at Publisher · View at Google Scholar · View at PubMed
  56. G. Cormio, V. Loizzi, M. Falagario, A. A. Lissoni, L. Resta, and L. E. Selvaggi, “Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994,” International Journal of Gynecology and Obstetrics, vol. 114, no. 2, pp. 133–136, 2011. View at Publisher · View at Google Scholar · View at PubMed
  57. D. Pectasides, M. Pectasides, and T. Economopoulos, “Brain metastases from epithelial ovarian cancer: a review of the literature,” Oncologist, vol. 11, no. 3, pp. 252–260, 2006. View at Publisher · View at Google Scholar · View at PubMed
  58. B. Melichar, H. Urminská, T. Kohlová, M. Nová, and T. Česák, “Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature,” Gynecologic Oncology, vol. 94, no. 2, pp. 267–276, 2004. View at Publisher · View at Google Scholar · View at PubMed
  59. L. Victoria, M. D. Seewaldt, C. David et al., “Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancy,” Gynecologic Oncology, vol. 55, no. 3, pp. 456–458, 1994. View at Publisher · View at Google Scholar · View at PubMed
  60. K. G. Cooper, H. C. Kitchener, and D. E. Parkin, “Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin,” Gynecologic Oncology, vol. 55, no. 2, pp. 318–323, 1994. View at Publisher · View at Google Scholar · View at PubMed
  61. G. Cormio, A. Gabriele, A. Maneo, G. Zanetta, C. Bonazzi, and F. Landoni, “Complete remission of brain metastases from ovarian carcinoma with carboplatin,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 78, no. 1, pp. 91–93, 1998. View at Publisher · View at Google Scholar
  62. M. Marinaccio, V. Pinto, S. Geusa, G. Lanzilotti, and L. Loiudice, “Solitary intracranial metastases from primary endometrioid ovarian cancer,” Archives of Gynecology and Obstetrics, vol. 261, no. 1, pp. 45–49, 1997. View at Publisher · View at Google Scholar
  63. D. Scott McMeekin, S. A. Kamelle, S. A. Vasilev et al., “Ovarian cancer metastatic to the brain: what is the optimal management?” Journal of Surgical Oncology, vol. 78, no. 3, pp. 194–200, 2001. View at Publisher · View at Google Scholar · View at PubMed
  64. G. Cormio, V. Loizzi, and L. Selvaggi, “Leptomeningeal involvement after remission of brain metastases from ovarian cancer,” International Journal of Gynecology and Obstetrics, vol. 99, no. 2, p. 139, 2007. View at Publisher · View at Google Scholar · View at PubMed
  65. J. P. Micha, B. H. Goldstein, J. V. Hunter, M. A. Rettenmaier, and J. V. Brown, “Long-term survival in an ovarian cancer patient with brain metastases,” Gynecologic Oncology, vol. 92, no. 3, pp. 978–980, 2004. View at Publisher · View at Google Scholar · View at PubMed
  66. S. H. Shen, C. R. Lai, H. D. Sun et al., “Brain metastasis of ovarian epithelial carcinoma,” Taiwanese Journal of Obstetrics and Gynecology, vol. 49, no. 1, pp. 101–104, 2010. View at Publisher · View at Google Scholar
  67. X. Q. Hu, J. Imitola, R. Y. Kim, A. Mahta, and S. Kesari, “Brain metastasis from ovarian cancer: case report and review of the literature,” Medical Oncology. In press.
  68. A. Watanabe, M. Shimada, J. Kigawa et al., “The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer,” International Journal of Clinical Oncology, vol. 10, no. 1, pp. 69–71, 2005. View at Publisher · View at Google Scholar · View at PubMed
  69. A. Sood, L. Kumar, R. Sood, and M. S. Sandhu, “Epithelial ovarian carcinoma metastatic to the central nervous system: a report on two cases with review of literature,” Gynecologic Oncology, vol. 62, no. 1, pp. 113–118, 1996. View at Publisher · View at Google Scholar · View at PubMed
  70. A. Sulkes, T. Siegal, and E. Gez, “Spontaneous intracranial hemorrhage in a patient with ovarian carcinoma,” Gynecologic Oncology, vol. 20, no. 2, pp. 204–208, 1985. View at Google Scholar
  71. G. Cormio, A. Maneo, A. Colamaria, G. Loverro, A. Lissoni, and L. Selvaggi, “Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases,” Gynecologic Oncology, vol. 89, no. 1, pp. 116–119, 2003. View at Publisher · View at Google Scholar
  72. S. E. Akhan, M. Işikoglu, Y. Salihoglu, E. Bengisu, and S. Berkman, “Brain metastasis of ovarian cancer after negative second-look laparotomy,” European Journal of Gynaecological Oncology, vol. 23, no. 4, pp. 330–332, 2002. View at Google Scholar
  73. M. Deutsch, D. Beck, D. Manor, and J. Brandes, “Metastatic brain tumor following negative second-look operation for ovarian carcinoma,” Gynecologic Oncology, vol. 27, no. 1, pp. 116–120, 1987. View at Google Scholar
  74. M. A. Izquierdo, B. Ojeda, C. Pallares, M. C. Alonso, and X. Matias-Guiu, “Ovarian carcinoma preceded by cerebral metastasis: review of the literature,” Gynecologic Oncology, vol. 45, no. 2, pp. 206–210, 1992. View at Publisher · View at Google Scholar
  75. J. Menczer, G. Ben-Baruch, S. Rizel, and H. Brenner, “Extraperitoneal metastases after intraperitoneal chemotherapy of ovarian cancer patients with a negative second-look laparotomy,” International Journal of Gynecological Cancer, vol. 3, no. 6, pp. 359–362, 1993. View at Publisher · View at Google Scholar
  76. B. Bakar and I. H. Tekkök, “Primary undifferentiated ovarian carcinoma diagnosed by its metastasis to brain: an unusual case report,” Turkish Neurosurgery, vol. 18, no. 4, pp. 431–435, 2008. View at Google Scholar
  77. K. Matsunami, A. Imai, T. Tamaya, H. Takagi, and K. Noda, “Brain metastasis as first manifestation of ovarian cancer,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 82, no. 1, pp. 81–83, 1999. View at Publisher · View at Google Scholar
  78. L. Gaspar, C. Scott, M. Rotman et al., “Recursive Partitioning Analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 4, pp. 745–751, 1997. View at Publisher · View at Google Scholar
  79. L. E. Gaspar, C. Scott, K. Murray, and W. Curran, “Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 4, pp. 1001–1006, 2000. View at Publisher · View at Google Scholar
  80. E. Weltman, J. V. Salvajoli, R. A. Brandt et al., “Radiosurgery for brain metastases: a score index for predicting prognosis,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 5, pp. 1155–1161, 2000. View at Publisher · View at Google Scholar
  81. J. Lorenzoni, D. Devriendt, N. Massager et al., “Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 1, pp. 218–224, 2004. View at Publisher · View at Google Scholar · View at PubMed
  82. Y. Z. Kim, K. H. Kim, J. S. Kim, Y. J. Song, K. U. Kim, and H. D. Kim, “Clinical analysis of patients who survived for less than 3 months after brain metastatectomy,” Journal of Korean Medical Science, vol. 24, no. 4, pp. 641–648, 2009. View at Publisher · View at Google Scholar · View at PubMed
  83. K. Kawana, H. Yoshikawa, H. Yokota et al., “Successful treatment of brain metastases from ovarian cancer using gamma-knife radiosurgery,” Gynecologic Oncology, vol. 65, no. 2, pp. 357–359, 1997. View at Publisher · View at Google Scholar · View at PubMed